Your browser doesn't support javascript.
loading
Oncogenic HER2{Delta}16 suppresses miR-15a/16 and deregulates BCL-2 to promote endocrine resistance of breast tumors.
Cittelly, Diana M; Das, Partha M; Salvo, Virgilio A; Fonseca, Juan P; Burow, Matthew E; Jones, Frank E.
Affiliation
  • Cittelly DM; Department of Pathology, School of Medicine, University of Colorado Denver, Aurora, CO 80045, USA.
Carcinogenesis ; 31(12): 2049-57, 2010 Dec.
Article in En | MEDLINE | ID: mdl-20876285
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tamoxifen / Breast Neoplasms / Receptor, ErbB-2 / Genes, bcl-2 / MicroRNAs / Estrogen Antagonists Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Carcinogenesis Year: 2010 Document type: Article Affiliation country: United States Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tamoxifen / Breast Neoplasms / Receptor, ErbB-2 / Genes, bcl-2 / MicroRNAs / Estrogen Antagonists Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Carcinogenesis Year: 2010 Document type: Article Affiliation country: United States Country of publication: United kingdom